2m 2m 2m 2m 2m 2m 2m
CELCUITY (CELC)
NASDAQ
$85.03+$1.58 (+1.89%)
Price as of Sep 11, 2026 7:46 PM EDT- $4.1BMarket Cap
- 51.98%1-Year Change
- BiotechnologyIndustry
CELCUITY (CELC)
$85.03+$1.58 (+1.89%)
CELC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $83.45 | ||
Change | -$2.04 (-2.39%) | ||
Open | $86.38 | ||
High | $87.01 | ||
Low | $83.23 | ||
Previous Close | $85.49 | ||
Volume | 863,369 | ||
30-Day Average Volume | 828,114 | ||
1-Week Change | -12.80% | ||
1-Month Change | -5.29% | ||
1-Year Change | 51.98% | ||
3-Year Change | 792.51% | ||
5-Year Change | 294.00% | ||
Fundamentals | |||
Shares Outstanding | 48.9M | ||
Total Assets | $828.2M | ||
Market Cap | $4.1B | ||
Enterprise Value | $4.7B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$55.5M | ||
EBIT | $300,000.00 | ||
EBITDA | $359,000.00 | ||
Net Working Capital | $689.0M | ||
EPS | -$1.44 | ||
Enterprise Value/EBITDA | 12,965 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -58 | ||
PEG | 1 | ||
Price/Free Cash Flow | -74 | ||
Price/Operating Cash Flow | -74 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue